title: Age-adjusted stroke incidence increase: could angiotensin AT1 receptor antagonists enhance stroke prevention?
authors.forename: Albert
authors.initials: A
authors.lastname: Fournier
authors.forename: Roxana
authors.initials: R
authors.lastname: Oprisiu
authors.forename: Michel
authors.initials: M
authors.lastname: Andrejak
authors.forename: Olivier
authors.initials: O
authors.lastname: Godefroy
authors.forename: Alain
authors.initials: A
authors.lastname: Rosa
authors.forename: Jean Michel
authors.initials: JM
authors.lastname: Achard
mesh_terms: D017677:Age Distribution; D000368:Aged; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015897:Comorbidity; D004232:Diuretics / Q000627:therapeutic use; D006760:Hospitalization / Q000639:trends; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology; D015994:Incidence; D015995:Prevalence; D044140:Receptor, Angiotensin, Type 1; D020521:Stroke / Q000453:epidemiology* / Q000517:prevention & control*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D004232:Diuretics; D044140:Receptor, Angiotensin, Type 1